drugset / Trial / NCT06900192
A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis
NaSequentialOpen-labelTreatment
Summary
A study of alloHCT with Orca-Q for the treatment of primary progressive multiple sclerosis (MS).
Timeline
- Start
- 2025-03
- Primary completion
- 2029-08
- Completion
- 2029-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orca-Q | Cell therapy | — | — |
| Background | Busulfan | Small molecule | — | — |
| Background | Fludarabine | Small molecule | — | — |
| Background | Thiotepa | Other / unclassified | — | — |